Bal Pharma

{
  "main_header": {
    "sid": 555664,
    "name": "Bal Pharma",
    "stock_name": "Bal Pharma",
    "full_name": "Bal Pharma Ltd",
    "name_url": "stocks-analysis/bal-pharma",
    "exchange": 0,
    "exchangecode": "",
    "primexch": 1,
    "country_id": 34,
    "currency": "INR",
    "cmp": "77.30",
    "chg": "0.00",
    "chgp": "0.00%",
    "dir": 0,
    "prev_price": "77.30",
    "mcapval": "124.00 Cr",
    "mcap": "Micro Cap",
    "scripcode": 524824,
    "symbol": "BALPHARMA",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 4,
    "indexname": "India SENSEX",
    "isin": "INE083D01012",
    "curr_date": "Apr 17",
    "curr_time": "",
    "bse_nse_vol": "6.04 k",
    "exc_status": "Active",
    "traded_date": "Apr 17, 2026",
    "traded_date_str": "2026 04 17",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-register-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/bal-pharma-555664-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "Bal Pharma Ltd is Rated Strong Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/bal-pharma-ltd-is-rated-strong-sell-3951889",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/4/BalPharmaLtd_mojoScore_3951889.png",
        "date": "2026-04-18 10:10:38",
        "description": "Bal Pharma Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 28 May 2025. However, the analysis and financial metrics discussed here reflect the stock’s current position as of 18 April 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trends, and technical outlook."
      },
      {
        "title": "Bal Pharma Ltd is Rated Strong Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/bal-pharma-ltd-is-rated-strong-sell-3934867",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/4/BalPharmaLtd_mojoScore_3934867.png",
        "date": "2026-04-07 10:10:45",
        "description": "Bal Pharma Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 28 May 2025. However, the analysis and financial metrics discussed here reflect the stock’s current position as of 07 April 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trend, and technical outlook."
      },
      {
        "title": "Markets Rally, But Bal Pharma Ltd Sinks to 52-Week Low in Stock-Specific Sell-Off",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/bal-pharma-ltd-falls-to-52-week-low-of-rs622-amid-market-downturn-3925565",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/BalPharmaLtd_priceRelatedfactors_3925565.png",
        "date": "2026-03-30 15:05:15",
        "description": ""
      },
      {
        "title": "Bal Pharma Ltd Falls to 52-Week Low of Rs 64 as Sell-Off Deepens",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/bal-pharma-ltd-falls-to-52-week-low-amidst-weak-market-and-fundamental-pressures-3920090",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/BalPharmaLtd_priceRelatedfactors_3920090.png",
        "date": "2026-03-27 15:05:10",
        "description": "For the fifth consecutive session, Bal Pharma Ltd closed lower, slipping to a fresh 52-week low of Rs 64 on 27 Mar 2026. This decline comes amid a broader market downturn, but the stock’s underperformance remains pronounced compared to its sector and benchmark indices."
      },
      {
        "title": "Bal Pharma Ltd is Rated Strong Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/bal-pharma-ltd-is-rated-strong-sell-3918904",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/BalPharmaLtd_mojoScore_3918904.png",
        "date": "2026-03-27 10:10:27",
        "description": "Bal Pharma Ltd is rated Strong Sell by MarketsMOJO. This rating was last updated on 28 May 2025. However, the analysis and financial metrics discussed below reflect the stock’s current position as of 27 March 2026, providing investors with the most up-to-date view of the company’s fundamentals, returns, and market performance."
      },
      {
        "title": "Bal Pharma Ltd Falls to 52-Week Low Amid Continued Downtrend",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/bal-pharma-ltd-falls-to-52-week-low-amid-continued-downtrend-3897007",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/BalPharmaLtd_priceRelatedfactors_3897007.png",
        "date": "2026-03-17 16:01:09",
        "description": "Bal Pharma Ltd’s shares have declined to within 3.03% of their 52-week low, marking a significant downturn for the micro-cap pharmaceutical company. The stock closed near Rs 66, approaching its lowest price point of Rs 64 over the past year, reflecting ongoing pressures in its market performance and fundamentals."
      },
      {
        "title": "Bal Pharma Ltd is Rated Strong Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/bal-pharma-ltd-is-rated-strong-sell-3892098",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/BalPharmaLtd_mojoScore_3892098.png",
        "date": "2026-03-15 10:10:23",
        "description": "Bal Pharma Ltd is rated Strong Sell by MarketsMOJO. This rating was last updated on 28 May 2025. However, the analysis and financial metrics presented here reflect the stock’s current position as of 15 March 2026, providing investors with the latest insights into the company’s performance and outlook."
      },
      {
        "title": "Bal Pharma Ltd is Rated Strong Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/bal-pharma-ltd-is-rated-strong-sell-3866193",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/BalPharmaLtd_mojoScore_3866193.png",
        "date": "2026-03-03 10:10:34",
        "description": "Bal Pharma Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 28 May 2025. However, the analysis and financial metrics discussed below reflect the stock’s current position as of 03 March 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trends, and technical outlook."
      },
      {
        "title": "Bal Pharma Ltd is Rated Strong Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/bal-pharma-ltd-is-rated-strong-sell-3848078",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/2/BalPharmaLtd_mojoScore_3848078.png",
        "date": "2026-02-20 10:10:49",
        "description": "Bal Pharma Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 28 May 2025. However, the analysis and financial metrics discussed below reflect the stock’s current position as of 20 February 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trends, and technical outlook."
      }
    ],
    "total": 134,
    "sid": "555664",
    "stock_news_url": "https://www.marketsmojo.com/news/bal-pharma-555664"
  },
  "announcements": [
    {
      "caption": "Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018",
      "datetime": "06-Apr-2026",
      "details": "Certificate under Regulation 74(5) of SEBI(DP) Regulations for the quarter ended 31.03.2026.",
      "source": "BSE"
    },
    {
      "caption": "Closure of Trading Window",
      "datetime": "23-Mar-2026",
      "details": "Closure of Trading Window for the quarter and financial year ended 31.03.2026.",
      "source": "BSE"
    },
    {
      "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication",
      "datetime": "16-Feb-2026",
      "details": "Newspaper publication of Unaudited financial results for the quarter ended 31.12.2025.",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "",
      "data": [
        {
          "txt": "Bal Pharma Ltd has declared <strong>12%</strong> dividend, ex-date: 18 Sep 25",
          "dt": "2025-09-18",
          "middle_text": "Dividend Alert"
        }
      ]
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}

News and Views

Bal Pharma Ltd is Rated Strong Sell

2026-04-18 10:10:38

Bal Pharma Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 28 May 2025. However, the analysis and financial metrics discussed here reflect the stock’s current position as of 18 April 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trends, and technical outlook.

Read full news article

Bal Pharma Ltd is Rated Strong Sell

2026-04-07 10:10:45

Bal Pharma Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 28 May 2025. However, the analysis and financial metrics discussed here reflect the stock’s current position as of 07 April 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trend, and technical outlook.

Read full news article

Markets Rally, But Bal Pharma Ltd Sinks to 52-Week Low in Stock-Specific Sell-Off

2026-03-30 15:05:15

Read full news article

Bal Pharma Ltd Falls to 52-Week Low of Rs 64 as Sell-Off Deepens

2026-03-27 15:05:10

For the fifth consecutive session, Bal Pharma Ltd closed lower, slipping to a fresh 52-week low of Rs 64 on 27 Mar 2026. This decline comes amid a broader market downturn, but the stock’s underperformance remains pronounced compared to its sector and benchmark indices.

Read full news article

Bal Pharma Ltd is Rated Strong Sell

2026-03-27 10:10:27

Bal Pharma Ltd is rated Strong Sell by MarketsMOJO. This rating was last updated on 28 May 2025. However, the analysis and financial metrics discussed below reflect the stock’s current position as of 27 March 2026, providing investors with the most up-to-date view of the company’s fundamentals, returns, and market performance.

Read full news article

Bal Pharma Ltd Falls to 52-Week Low Amid Continued Downtrend

2026-03-17 16:01:09

Bal Pharma Ltd’s shares have declined to within 3.03% of their 52-week low, marking a significant downturn for the micro-cap pharmaceutical company. The stock closed near Rs 66, approaching its lowest price point of Rs 64 over the past year, reflecting ongoing pressures in its market performance and fundamentals.

Read full news article

Bal Pharma Ltd is Rated Strong Sell

2026-03-15 10:10:23

Bal Pharma Ltd is rated Strong Sell by MarketsMOJO. This rating was last updated on 28 May 2025. However, the analysis and financial metrics presented here reflect the stock’s current position as of 15 March 2026, providing investors with the latest insights into the company’s performance and outlook.

Read full news article

Bal Pharma Ltd is Rated Strong Sell

2026-03-03 10:10:34

Bal Pharma Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 28 May 2025. However, the analysis and financial metrics discussed below reflect the stock’s current position as of 03 March 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trends, and technical outlook.

Read full news article

Bal Pharma Ltd is Rated Strong Sell

2026-02-20 10:10:49

Bal Pharma Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 28 May 2025. However, the analysis and financial metrics discussed below reflect the stock’s current position as of 20 February 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trends, and technical outlook.

Read full news article

View All News